Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) Part I. Pathophysiology, clinical symptoms and recommend screening for vascular malformations.

Hereditární hemoragická teleangiektázie (syndrom Osler-Weber-Rendu) Díl I. Patofyziologie, klinické příznaky a doporučený skrínink cévních malformací.
arteriovenous malformation arteriovenous malformations hereditary haemorrhagic telangiectasia hereditary hemorrhagic teleangiectasia

Journal

Vnitrni lekarstvi
ISSN: 0042-773X
Titre abrégé: Vnitr Lek
Pays: Czech Republic
ID NLM: 0413602

Informations de publication

Date de publication:
2021
Historique:
entrez: 23 4 2022
pubmed: 1 1 2021
medline: 27 4 2022
Statut: ppublish

Résumé

Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is an autosomal dominant disorder that causes abnormal blood vessel formation. Patients with HHT may have telangiectasias and later may develop arteriovenous malformations in various organs. Pacients suffer from many complications caused by the malformations and therefore by patients with HHT must by performed screening of this arteriovenous malformations. Optimal treatment of this malformations is best delivered throught a multidisciplinary approach. Farmacological treatment is described in next paper.

Identifiants

pubmed: 35459376
pii: 130094

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

339-344

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH